Brief: Silence Therapeutics Achieves $10 Million Milestone Payment From Astrazeneca Collaboration
04/05/2023 12:15
Silence Therapeutics PLC SLNCF.PK :
* SILENCE THERAPEUTICS ACHIEVES $10 MILLION MILESTONE
PAYMENT FROM
ASTRAZENECA COLLABORATION
Source text for Eikon: ID:nBw6MXyfJa
Further company coverage: SLNCF.PK
Recent news on Silence Therapeutics
See all newsBrief: Silence Therapeutics Reports Second Quarter 2025 Financial Results And Recent Business Highlights
Brief: Silence Therapeutics files for stock shelf, size not disclosed
Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study
Brief: Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study Of Zerlasiran In Patients With Elevated Lipoprotein
Brief: Silence Therapeutics PLC Files For Resale Of Up To 5.71 Million Shares By The Selling Securityholders - SEC Filing